Your browser doesn't support javascript.
loading
Time trends (2006-2015) of quality indicators in EUSOMA-certified breast centres.
van Dam, P A; Tomatis, M; Marotti, L; Heil, J; Mansel, R E; Rosselli Del Turco, M; van Dam, P J; Casella, D; Bassani, L G; Danei, M; Denk, A; Egle, D; Emons, G; Friedrichs, K; Harbeck, N; Kiechle, M; Kimmig, R; Koehler, U; Kuemmel, S; Maass, N; Mayr, C; Prové, A; Rageth, C; Regolo, L; Lorenz-Salehi, F; Sarlos, D; Singer, C; Sohn, C; Staelens, G; Tinterri, C; Audisio, R; Ponti, A.
Afiliación
  • van Dam PA; Breast Unit, Antwerp University Hospital, Edegem, Belgium. Electronic address: peter.vandam@telenet.be.
  • Tomatis M; AOU Città Della Salute e Della Scienza, CPO Piemonte and EUSOMA, Data Centre, Turin, Italy.
  • Marotti L; EUSOMA, Florence, Italy.
  • Heil J; Breast Unit, University of Heidelberg, Germany.
  • Mansel RE; School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Rosselli Del Turco M; EUSOMA, Florence, Italy.
  • van Dam PJ; Translational Cancer Research Unit, University of Antwerp (CORE), Wilrijk, Belgium.
  • Casella D; AOU Città Della Salute e Della Scienza, CPO Piemonte and EUSOMA, Data Centre, Turin, Italy.
  • Bassani LG; Centro Senologia Multimedica Castellanza, Italy.
  • Danei M; Brustcentrum Am Marienhospital Aachen, Germany.
  • Denk A; Brustzentrum St. Joseph-Stift Bremen, Germany.
  • Egle D; BrustGesundheitZentrum Tirol, Medical University Innsbruck, Austria.
  • Emons G; Universitaets Frauenklinik Gottingen, Germany.
  • Friedrichs K; Mammazentrum Hamburg, Germany.
  • Harbeck N; Breast Center, University of Munich (LMU), Munich, Germany.
  • Kiechle M; Klinikum Rechts der Isar der Technischen Universitaet, Munich, Germany.
  • Kimmig R; West German Cancer Centre, Breast Unit, University Hospital Essen, Germany.
  • Koehler U; Breast Cancer Centre "St. Georg" Leipzig, Germany.
  • Kuemmel S; Breast Unit, Kliniken Essen Mitte, Germany.
  • Maass N; Klinik für Gynäkologie und Geburtshilfe, Kiel, Germany.
  • Mayr C; GIPMa, Comprensorio Sanitario di Bolzano, Italy.
  • Prové A; Breast Center Sint Augustinus, Wilrijk, Belgium.
  • Rageth C; Breast Center Zurich, Switzerland.
  • Regolo L; Maugeri Foundation, Pavia, Italy.
  • Sarlos D; Brustzentrum Mittelland Kantonsspitäler Aarau/Olten, Switzerland.
  • Singer C; Medical University of Vienna, Austria.
  • Sohn C; Breast Unit, University of Heidelberg, Germany.
  • Staelens G; Borstkliniek Kortrijk AZ Groeninge, Belgium.
  • Tinterri C; Breast Unit Humanitas Cancer Centre, Rozzano, Italy.
  • Audisio R; St Helens Teaching Hospital, University of Liverpool, United Kingdom.
  • Ponti A; AOU Città Della Salute e Della Scienza, CPO Piemonte and EUSOMA, Data Centre, Turin, Italy.
Eur J Cancer ; 85: 15-22, 2017 11.
Article en En | MEDLINE | ID: mdl-28881247
ABSTRACT
AIM OF THE STUDY The European Society of Breast Cancer Specialists (EUSOMA) has fostered a voluntary certification process for breast centres to establish minimum standards and ensure specialist multidisciplinary care. Prospectively collected anonymous information on primary breast cancer cases diagnosed and treated in the units is transferred annually to a central EUSOMA data warehouse for continuous monitoring of quality indicators (QIs) to improve quality of care. Units have to comply with the EUSOMA Breast Centre guidelines and are audited by peers. The database was started in 2006 and includes over 110,000 cancers from breast centres located in Germany, Switzerland, Belgium, Austria, The Netherlands, Spain, Portugal and Italy. The aim of the present study is assessing time trends of QIs in EUSOMA-certified breast centres over the decade 2006-2015. MATERIALS AND

METHODS:

Previously defined QIs were calculated for 22 EUSOMA-certified breast centres (46122 patients) during 2006-2015.

RESULTS:

On the average of all units, the minimum standard of care was achieved in 8 of 13 main EUSOMA QIs in 2006 and in all in 2015. All QIs, except removal of at least 10 lymph nodes at axillary clearance and oestrogen receptor-negative tumours (T > 1 cm or N+) receiving adjuvant chemotherapy, improved significantly in this period. The desirable target was reached for two QIs in 2006 and for 7 of 13 QIs in 2015.

CONCLUSION:

The EUSOMA model of audit and monitoring QIs functions well in different European health systems and results in better performance of QIs over the last decade. QIs should be evaluated and adapted on a regular basis, as guidelines change over time.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Evaluación de Procesos, Atención de Salud / Prestación Integrada de Atención de Salud / Indicadores de Calidad de la Atención de Salud Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Female / Humans País/Región como asunto: Europa Idioma: En Revista: Eur J Cancer Año: 2017 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Evaluación de Procesos, Atención de Salud / Prestación Integrada de Atención de Salud / Indicadores de Calidad de la Atención de Salud Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Female / Humans País/Región como asunto: Europa Idioma: En Revista: Eur J Cancer Año: 2017 Tipo del documento: Article